Manhattan Bridge Capital Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Bridge Capital in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Manhattan Bridge Capital stock.
View analyst ratings for Manhattan Bridge Capital or view top-rated stocks.

Wall Street analysts have given Manhattan Bridge Capital a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Manhattan Bridge Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Manhattan Bridge Capital saw a decrease in short interest during the month of May. As of May 28th, there was short interest totaling 25,900 shares, a decrease of 14.8% from the May 13th total of 30,400 shares. Based on an average daily trading volume, of 29,100 shares, the short-interest ratio is currently 0.9 days. Approximately 0.4% of the company's stock are sold short.
View Manhattan Bridge Capital's Short Interest.

Manhattan Bridge Capital is scheduled to release its next quarterly earnings announcement on Thursday, July 22nd 2021.
View our earnings forecast for Manhattan Bridge Capital.

Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) posted its quarterly earnings results on Tuesday, April, 13th. The credit services provider reported $0.12 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.12. Manhattan Bridge Capital had a net margin of 61.49% and a trailing twelve-month return on equity of 13.20%.
View Manhattan Bridge Capital's earnings history.

Manhattan Bridge Capital's stock was trading at $5.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, LOAN stock has increased by 42.7% and is now trading at $7.25.
View which stocks have been most impacted by COVID-19.

Manhattan Bridge Capital announced a quarterly dividend on Friday, April 16th. Shareholders of record on Friday, July 9th will be given a dividend of $0.125 per share on Thursday, July 15th. This represents a $0.50 annualized dividend and a dividend yield of 6.90%. The ex-dividend date of this dividend is Thursday, July 8th. This is a positive change from Manhattan Bridge Capital's previous quarterly dividend of $0.11.
View Manhattan Bridge Capital's dividend history.

Manhattan Bridge Capital pays an annual dividend of $0.44 per share and currently has a dividend yield of 6.07%. LOAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Manhattan Bridge Capital's dividend history.

1 brokers have issued twelve-month price objectives for Manhattan Bridge Capital's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Manhattan Bridge Capital's stock price to reach $6.00 in the next year. This suggests that the stock has a possible downside of 17.2%.
View analysts' price targets for Manhattan Bridge Capital or view top-rated stocks among Wall Street analysts.

Some companies that are related to Manhattan Bridge Capital include Bluerock Residential Growth REIT (BRG), Transcontinental Realty Investors (TCI), Postal Realty Trust (PSTL), Western Asset Mortgage Capital (WMC), Alpine Income Property Trust (PINE), AG Mortgage Investment Trust (MITT), Cedar Realty Trust (CDR), Pennsylvania Real Estate Investment Trust (PEI), Cherry Hill Mortgage Investment (CHMI), Maxus Realty Trust (MRTI), New York City REIT (NYC), ACRES Commercial Realty (ACR), Ellington Residential Mortgage REIT (EARN), CIM Commercial Trust (CMCT) and Sachem Capital (SACH).
View all of LOAN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer (ET), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), B&G Foods (BGS), Enterprise Products Partners (EPD), Global Medical REIT (GMRE), Kimco Realty (KIM), Mylan (MYL) and Rigel Pharmaceuticals (RIGL).

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital's stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (1.66%), Hardy Reed LLC (0.64%) and BlackRock Inc. (0.26%). Company insiders that own Manhattan Bridge Capital stock include Assaf Ran, Eran Goldshmit, Lyron L Bentovim and Vanessa Kao.
View institutional ownership trends for Manhattan Bridge Capital.

LOAN stock was sold by a variety of institutional investors in the last quarter, including Hardy Reed LLC.
View insider buying and selling activity for Manhattan Bridge Capital or view top insider-selling stocks.

LOAN stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and BlackRock Inc.. Company insiders that have bought Manhattan Bridge Capital stock in the last two years include Assaf Ran, and Vanessa Kao.
View insider buying and selling activity for Manhattan Bridge Capital or or view top insider-buying stocks.

Shares of LOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LOAN stock can currently be purchased for approximately $7.25.

Manhattan Bridge Capital has a market capitalization of $69.75 million and generates $7.01 million in revenue each year.

Manhattan Bridge Capital employs 5 workers across the globe.

The official website for Manhattan Bridge Capital is www.manhattanbridgecapital.com.

Manhattan Bridge Capital is headquartered at 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The credit services provider can be reached via phone at 516-444-3400.